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Clostridium difficile is a leading cause of nosocomial infections, causing a spectrum of diseases
ranging from diarrhoea to pseudomembranous colitis triggered by a range of virulence factors
including C. difficile toxins A (TcdA) and B (TcdB). TcdA and TcdB are monoglucosyltransferases
that irreversibly glycosylate small Rho GTPases, inhibiting their ability to interact with their
effectors, guanine nucleotide exchange factors, and membrane partners, leading to disruption of
downstream signalling pathways and cell death. In addition, TcdB targets the mitochondria,
inducing the intrinsic apoptotic pathway resulting in TcdB-mediated apoptosis. Modulation of
apoptosis is a common strategy used by infectious agents. Recently, we have shown that the
enteropathogenic Escherichia coli (EPEC) type III secretion system effector NleH has a
broad-range anti-apoptotic activity. In this study we examined the effects of NleH on cells
challenged with TcdB. During infection with wild-type EPEC, NleH inhibited TcdB-induced
apoptosis at both low and high toxin concentrations. Transfected nleH1 alone was sufficient to
block TcdB-induced cell rounding, nuclear condensation, mitochondrial swelling and lysis, and
activation of caspase-3. These results show that NleH acts via a global anti-apoptotic pathway.
INTRODUCTION
Enteropathogenic Escherichia coli (EPEC) and enterohae-
morrhagic E. coli (EHEC) are closely related and important
extracellular pathogens (Chen & Frankel, 2005; Nataro &
Kaper, 1998) that while intimately adhering to gut
enterocytes induce localized effacement of brush-border
microvilli (Knutton et al., 1987). Injection of bacterial
effector proteins via a type III secretion system (T3SS) is an
integral part of the EPEC and EHEC infection strategy
(Frankel et al., 1998; Garmendia et al., 2005; Iguchi et al.,
2009; Tobe et al., 2006) that reprogrammes cell signalling
processes to facilitate colonization and infection
(Garmendia et al., 2005).
Among the conserved EPEC and EHEC effectors, Tir, EspG
and Map subvert actin dynamics (Caron et al., 2006), while
EspF (McNamara et al., 2001) disrupts the mitochondrial
membrane potential and tight junctions. EspF also binds to
and induces degradation of the anti-apoptotic protein
AbcF2 (Nougayrede et al., 2007). Importantly, EPEC-
infected cells exhibit only early features of apoptosis,
including expression of phosphatidylserine on the cell
surface, and cleavage of cellular DNA and cytokeratin 18.
However, EPEC-infected cells do not exhibit late apoptotic
symptoms, including cell shrinkage, membrane blebbing or
nuclear condensation and fragmentation (Crane et al.,
1999, 2001). As apoptosis relies on a fine balance between
pro- and anti-apoptotic factors, we hypothesized the
existence of effector(s) with anti-apoptotic activity, which
neutralize the effects of EspF and promote cell survival.
Indeed, we recently found that the EPEC T3SS effector
NleH has a broad range of anti-apoptotic activities
attributed to its interaction with the six-transmembrane
endoplasmic reticulum (ER) protein Bax inhibitor 1
(Hemrajani et al., 2010). We have shown that ectopic
expression of NleH blocked apoptosis induced by the pro-
apoptotic compounds staurosporine, a universal protein
kinase inhibitor, and brefeldin A and tunicamycin,
inducers of ER stress-related apoptosis (Hemrajani et al.,
2010). In particular, we have shown that expression of
NleH prevented key apoptotic symptoms, including
elevation of cytosolic Ca
2+ concentration, membrane
blebbing, nuclear condensation and activation of caspase-3.
Clostridium difficile is an anaerobic, spore-forming, Gram-
positive pathogen and a leading cause of nosocomial
infections (Bartlett et al., 1978; George et al., 1978; Rupnik
et al., 2009; Voth & Ballard, 2005). C. difficile is a
commensal bacterium, frequently carried asymptomat-
ically. However, antibiotic treatment of high-risk patients
Abbreviations: EHEC, enterohaemorrhagic E. coli; EPEC, enteropatho-
genic Escherichia coli; ER, endoplasmic reticulum; MMHP, mitochondrial
membrane hyperpolarization; T3SS, type III secretion system.
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leading to sporulation and multiplication of this bac-
terium. C. difficile infection can cause a variety of
symptoms ranging from diarrhoea to pseudomembranous
colitis, which is associated with a high mortality rate (Kyne
et al., 2002).
The major virulence factors of C. difficile are the clostridial
toxins A (TcdA) and B (TcdB) (Lyras et al., 2009; Mani
et al., 2002), which are encoded by the tcdA and tcdB genes,
respectively, located on a 19.6 kb pathogenicity locus
termed PaLoc (Mani et al., 2002; Matamouros et al., 2007).
TcdA and TcdB are monoglucosyltransferases that irre-
versibly glycosylate small Rho GTPases, inhibiting their
ability to interact with their effectors (Herrmann et al.,
1998; Sehr et al., 1998), guanine nucleotide exchange
factors (Herrmann et al., 1998; Sehr et al., 1998) and
membrane partner (Genth et al., 1999), leading to
disruption of downstream signalling pathways and cell
death (Just & Gerhard, 2004; Voth & Ballard, 2005).
Targeting of TcdA and TcdB to Rho(A/B/C), RhoG, TC10,
Rac1 and Cdc42 results in actin condensation, leading to
dramatic rearrangement of the cytoskeleton, upregulation
of pro-apoptotic factors (e.g. RhoB) and host cell rounding
(Genth et al., 2008; Voth & Ballard, 2005). Rho has a major
role in stress fibre formation, motility and focal adhesions,
whilst Rac1 and Cdc42 are involved in formation of
filopodia and lamellipodia. It has been suggested that
TcdB-treated cells require activation of the pro-apoptotic
factor RhoB, via TcdB inactivation of RhoA, in order to
induce the associated C. difficile cytotoxicity (Genth et al.,
2008). The cytopathic effects of TcdA and TcdB in tissue
remain partially ambiguous, and the emergence of clinical
isolates that are tcdB
+ tcdA
2 but which result in clinical
symptoms indistinguishable from tcdA
+ tcdB
+ strains
suggest that both toxins are not absolutely required for a
productive infection (Kato et al., 1998; Kuijper et al., 2001;
Limaye et al., 2000). Recent work has indicated that C.
difficile-induced apoptosis is due to TcdB inducing
mitochondrial hyperpermeability via disruption of the
mitochondrial membrane polarity, resulting in mitochon-
drial swelling, release of pro-apoptotic proteins and
eventual lysis, all promoting progression of the host cell
to apoptosis (Matarrese et al., 2007). Apoptosis is executed
via a number of different pathways, broadly differentiated
into either extrinsic or intrinsic, with the pathways being
either caspase dependent or independent. Caspases are
cysteine proteases which are activated by cleavage in a
hierarchical fashion and exist in the cytosol in zymogenic
form. Once activated, caspases are important in cleaving
key intracellular substrates, resulting in apoptosis
(Budihardjo et al., 1999). Bacterial virulence factors often
target the mitochondrial membrane to modulate host cell
death by permitting the release of pro-apoptotic proteins,
e.g. cytochrome c. The aim of this study was to examine if
NleH can inhibit TcdB-induced apoptosis.
METHODS
Bacterial strains and growth conditions. Bacterial strains and
plasmids used in this study are described in Table 1. Bacteria were
grown at 37 uC in Luria–Bertani (LB) broth or agar supplemented
with ampicillin (100 mgm l
21); chloramphenicol (25 mgm l
21) and
kanamycin (50 mgm l
21) as appropriate.
EPEC bacteria were cultured in LB broth at 37 uC for 18 h with the
required antibiotic. Overnight cultures were diluted at a ratio of
1:100 into colourless Dulbecco’s Modified Eagle’s Medium
(DMEM), containing 1000 mg glucose l
21, to prime expression of
the T3SS and effector proteins (Hemrajani et al., 2010), and incubated
for a further 3 h at 37 uC until the OD600 reached 0.3–0.35; strains
containing pSA10-nleH1 were induced for NleH expression with
1 mM IPTG for the final 30 min.
C. difficile toxin B preparation. Toxin B from C. difficile VPI10463
was prepared according to previously described methods Reineke
et al. (2007) and was a gift from Dr C. von Eichel-Streiber. The toxin
was examined by SDS-PAGE and deemed to be ¢95% pure.
Tissue culture and transfection. HeLa cells were grown in DMEM
containing 1000 mg glucose l
21 and supplemented with 10% (v/v)
fetal calf serum, non-essential amino acids and GlutaMAX in a
humidified atmosphere at 5% (v/v) CO2 at 37 uC. Cells were
Table 1. Strains and plasmids
Strain or plasmid Characteristics Source/reference
Strains
E2348/69 Wild-type EPEC O127:H6 Levine et al. (1978)
ICC217 E2348/69 DescN, escN::Kan (Kan
r) Garmendia et al. (2004)
ICC303 E2348/69 DnleH1DnleH2, nleH1::Kan, nleH2::Cm (Kan
r,C m
r) Hemrajani et al. (2010)
Plasmids
pSA10 pKK177-3 expression vector containing lacI gene Schlosser-Silverman et al.
(2000)
pICC443 pSA10-nleH1, derivative of pSA10, expressing NleH1 Hemrajani et al. (2010)
pHM6 Mammalian expression vector, N-term HA tag and C-term His-tag Roche
pICC449 pHM6-nleH1, derivative of pHM6, expressing HA-NleH1, stop codon before His-tag Hemrajani et al. (2010)
pEGFP-N1 Mammalian GFP expression vector Clontech
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(Clontech) (control plasmid) using lipofectamine 2000 (Invitrogen)
in accordance with the manufacturer’s protocol and incubated in a
humidified atmosphere for 24 h before adding 4 ng TcdB ml
21; cells
were then incubated for an additional 18 h. The transfection
efficiency for pICC443 was ~30–40% whilst control plasmids were
transfected at a higher efficiency of ~70% – this was controlled for
during counting, with 100 transfected cells counted in a field of view.
Cell viability assay. HeLa cells were grown in 24-well plates with
and without coverslips, washed and the growth medium replaced by
colourless DMEM. Primed bacteria were normalized by optical
density (OD600 0.35) and used to infect for 1 h. Cells were washed five
times with pre-warmed HBSS, treated with DMEM containing 200 mg
gentamicin ml
21 (Invitrogen) to kill the bacteria, and 4 ng ml
21 or
4 mgm l
21 of TcdB was added for 18 or 4 h respectively. Cells were
then washed three times in PBS (Sigma). Viability counting involved
trypsinizing (300 ml) the cells, followed by neutralization with 700 ml
DMEM, then viewing living cells using 0.05% trypan blue in PBS
mixed with cells at a ratio of 1:1 and counting in a Neubauer
haemocytometer. All conditions were tested a minimum of three
times and all counts were compared to the uninfected cells then
plotted as a percentage of viable cells.
Immunofluorescence and nuclear condensation. Mitochondrial
viability was tested using MitoTracker (Invitrogen) according to the
manufacturer’s guidelines before fixation. Cells were fixed in 3%
paraformaldehyde for 15 min at room temperature, washed,
quenched for 30 min with 10 mM NH4Cl, permeabilized with
0.2% Triton-X-100, washed again and incubated with 1% BSA for
1 h. Caspase-3 activation was examined by staining overnight at 4 uC
with monoclonal rabbit anti-cleaved caspase-3 (Cell Signalling
Technology) and cells transfected with pICC449 (pHM6-nleH1,
expressing an N-terminal HA tag) were visualized with mouse anti-
HA (Covance) diluted 1:500 in 1% BSA. Donkey anti-rabbit IgG
conjugatedto RRXanddonkey anti-mouse conjugatedto Cy2(Jackson
Laboratories) were diluted 1:200 in 1% BSA for 45 min. Nuclear
condensation was visualized by labelling DNA with Hoechst 33342
(Invitrogen) diluted 1:500 in 1% BSA; bacterial presence was observed
using rabbit anti-O127 diluted 1:500 and visualized with donkey anti-
rabbit RRX (Jackson Laboratories) diluted 1:200 in 1% BSA.
Following antibody incubation, and a further three additional washes
with PBS, the coverslips were mounted using ProLong Gold antifade
reagent (Invitrogen) and visualized with a Zeiss Axioimager immuno-
fluorescence microscope then analysed by Axiovision Rel 4.5 software.
Statistics. All statistical tests were done using GraphPad InStat
Version 3.06 software on data from experiments done in triplicate
and repeated a minimum of three times. Counts in experiments using
transfected or infected cells were carried out as described above, with
100 cells counted in each repeat. The one-way ANOVA test using
Bonferroni correction was used to determine significance.
RESULTS
NleH promotes cell survival by inhibiting TcdB-
mediated cell death
In order to examine if NleH has a cytoprotective activity in
cells exposed to TcdB, HeLa cells were infected for 1 h with
wild-type EPEC, EPEC DescN (T3SS-deficient mutant),
EPEC DnleH1/DnleH2 and EPEC DnleH1/DnleH2 comple-
mented with pICC443 (encoding NleH1) (Table 1).
Following protein translocation and washes the attached
bacteria were killed by the addition of gentamicin (200 mg
ml
21). HeLa cells were challenged with 4 ng TcdB ml
21 for
18 h and the number of viable cells quantified (Fig. 1a). In
the absence of toxin, infection with wild-type EPEC and
the DescN mutant did not significantly alter cell survival.
However, more than 40% of cells did not survive EPEC
DnleH1/DnleH2 infection; in trans expression of NleH1
(pICC443) in the double mutant partially restored cell
survival, as cell loss was reduced to ,20% (P,0.05)
(Fig. 1a). Exposure to 4 ng TcdB ml
21 for 18 h resulted in
a significant (.50%) decrease in the number of living cells
in uninfected control cultures and monolayers infected
with EPEC DescN and EPEC DnleH1/DnleH2 (P,0.05)
(Fig. 1a). In contrast, infection with wild-type EPEC
protected the monolayers, resulting in similar survival to
that of wild-type infected cells without TcdB challenge.
Complementation of the EPEC DnleH1/DnleH2 mutant
with pICC443 (encoding NleH1) resulted in partial
Fig. 1. NleH inhibits C. difficile toxin B-mediated cell death. Cell
viability counts were determined during infection of HeLa cells with
wild-type EPEC, EPEC DnleH1DnleH2 and the complemented
strain DnleH1DnleH2(pICC443). Uninfected and EPEC DescN-
infected cells were used as controls. Cells were left unchallenged
(white bars) or challenged (black bars) with 4 ng TcdB ml
”1 for
18 h (a) or 4 mg TcdB ml
”1 for 4 h (b). In the absence of toxin, cell
viability was significantly reduced following infection with EPEC
DnleH1DnleH2 compared with uninfected cells or cells infected
with wild-type EPEC.
NleH blocks C. difficile toxin B apoptosis
http://mic.sgmjournals.org 1817cytoprotection (Fig. 1a). Importantly, the same pattern was
observed when challenging HeLa cells infected with the
same EPEC strains with 4 mg TcdB ml
21 for 4 h following
the initial 1 h infection (P,0.001) (Fig. 1b). These results
show that delivery of NleH during EPEC infection can
protect cells from TcdB-induced cell death.
NleH inhibits nuclear condensation
We determined if NleH can block TcdB-induced nuclear
condensation. HeLa cells were infected with wild-type
EPEC, EPEC DescN,E P E CDnleH1/DnleH2 and EPEC
DnleH1/DnleH2 complemented with pICC443 (encoding
NleH1). Hoechst staining was used to visualize nuclear
condensation while bacterial adhesion was detected using
anti-O127 antiserum. Examples of nuclei considered to
be condensed are indicated by arrows in Fig. 2(a).
Quantification of condensed nuclei by fluorescence micro-
scopy showed that only 3% of uninfected HeLa cells
exhibited nuclear condensation, compared to 10% and 9%
of cells infected with wild-type EPEC and EPEC DescN,
respectively. In contrast, 44% of the cells in monolayers
infected with EPEC DnleH1DnleH2 exhibited nuclear
condensation, which is significantly higher (P,0.001) than
the level seen in the other infected monolayers (Fig. 2b,
white bars). Complementing the EPEC DnleH1DnleH2
strain with pICC443 (encoding NleH1) reduced the
frequency of cells with condensed nuclei to 19% (Fig. 2b,
white bars).
When challenged with 4 ng TcdB ml
21 TcdB for 18 h
(Fig. 2b, black bars), uninfected HeLa cells (47%) and cells
infected with EPEC DescN (52%) and EPEC DnleH1DnleH2
(56%) all showed a significant increase in nuclear
condensation (P,0.05) compared to the same conditions
in the absence of TcdB. However, HeLa cells infected with
wild-type EPEC and challenged with 4 ng TcdB ml
21
showed no significant change in nuclear condensation,
whilst cells infected with EPEC DnleH1DnleH2 comple-
mented with pICC443 (encoding NleH1) showed a
Uninfected E2348/69 ΔnleH1ΔnleH2
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Fig. 2. NleH prevents nuclear condensation
induced by TcdB. HeLa cells were infected
with wild-type EPEC, EPEC DnleH1DnleH2
and complemented mutant and stained with
Hoechst 33342 for evaluation of nuclear
condensation or fragmentation; uninfected
and EPEC DescN-infected cells were used
as controls (a). The number of condensed
nuclei (arrowed in a) was determined by
counting under an epifluorescence micro-
scope (b).
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TcdB-untreated HeLa cells.
NleH inhibits caspase-3 cleavage in the presence
of TcdB
TcdB-induced apoptosis is mediated by caspase-3
(Matarrese et al., 2007). In order to investigate if NleH
inhibits the cleavage of pro-caspase-3, HeLa cells were
transfected with nleH1 or with a gfp control and challenged
with 4 ng TcdB ml
21 for 18 h. The number of cells with
cleaved caspase-3 was assessed and quantified by immuno-
fluorescence microscopy. Typical images are shown in
Fig. 3(a); cells considered to have cleaved caspase-3 are
indicated by arrows. Cells ectopically expressing nleH1 did
not show any difference in caspase-3 activation whether
challenged with the toxin or not. However, both untrans-
fected cells and the negative control (gfp-transfected cells)
showed significantly higher caspase-3 activation (P,0.001)
(Fig. 3b). This result suggests that NleH is capable of
blocking TcdB-induced caspase-3 activation and therefore
the progression of apoptosis.
NleH prevents mitochondrial membrane
disruption
Recently it was reported that TcdB-induced apoptosis is
due to hyperpermeable mitochondria (Matarrese et al.,
2007). We tested if NleH can enhance mitochondrial
survival in cells challenged with TcdB. Mitochondrial
viability was examined in HeLa cells transfected with nleH1
or a gfp control and challenged with 4 ng TcdB ml
21 for
18 h. Mitochondrial viability was assessed using
MitoTracker, a dye permeable to active mitochondria,
Fig. 3. NleH1 prevents pro-caspase-3 cleav-
age induced by TcdB. Caspase-3 activation
was determined in cells transfected with nleH1
(pHM6-nleH1)o ragfp control (pEGFP-N1)
and treated with 4 ng TcdB ml
”1 for 18 h;
unchallenged cells were used as a control. (a)
Cells were stained with anti-HA (green) to
label HA-tagged NleH1 and anti-cleaved
caspase-3 (red) and visualized by immuno-
fluorescence. (b) The level of caspase-3
cleavage in transfected cells was determined
by counting under an epifluorescence micro-
scope. Black bars, TcdB-treated cells; white
bars, unchallenged controls. Expression of
NleH1 significantly prevented the cleavage of
pro-caspase-3 when cells were treated with
TcdB compared to mock-transfected cells or
cells transfected with pGFP.
NleH blocks C. difficile toxin B apoptosis
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are shown in Fig. 4. When cells were challenged with 4 ng
TcdB ml
21 for 18 h, both untransfected cells and cells
transfected with the gfp control exhibited loss of mito-
chondrial membrane potential, showing a condensed
mitochondrial pattern (Fig. 4b, arrows). The mitochondria
of cells transfected with nleH1 were capable of taking up
the MitoTracker dye, showing distinct mitochondria,
whilst both untransfected cells and gfp controls showed
uniform staining. This implies that NleH1 inhibits
cytochrome c release in large quantities by inhibiting
mitochondrial bursting, and/or that caspase-3 activation is
inhibited and therefore the intrinsic pathway of apoptosis
is not active in nleH1-transfected cells.
DISCUSSION
It has been reported that the apoptotic effects of TcdB are
potentially mediated in three different ways: firstly by
inhibiting Rho GTPases, resulting in the inhibition of
assembly of the actin cytoskeleton, which can lead to the loss
of anchorage to the substratum and result in morphological
changes related to apoptosis (Frankel et al., 1998; Just et al.,
1995; Lyras et al., 2009; Matarrese et al., 2007; Reineke et al.,
2007); secondly, by disruption of downstream signalling
events that Rho GTPases are involved in such as transcrip-
tion factor activation/inactivation (Le et al., 2005; Matarrese
et al., 2007); and thirdly, by disruption of the mitochondrial
membrane potential, thereby inducing the activation of
caspase-9 and ultimately caspases -3, -6 and -7 (Lyras et al.,
2009; Matarrese et al., 2007).
The inhibition of Rho GTPases has a dual effect on actin
assembly and downstream signalling events. Although the
inactivation of Rho GTPases has not been fully investigated
in this study it is evident that there is stabilization of the
actin cytoskeleton at the plasma membrane. HeLa cells that
were not transfected with nleH1 largely showed signs of cell
rounding following 18 h of exposure to TcdB (4 ng ml
21),
a hallmark of TcdB challenge. However, cells expressing
NleH1 maintained cell membrane integrity and did not
Fig. 4. NleH1 prevents mitochondrial lysis in
cells challenged with TcdB. Mitochondrial
membrane potential was examined in cells
transfected with nleH1 (pHM6-nleH1)o ragfp
control (pEGFP-N1) and treated or not with
4 ng TcdB ml
”1 for 18 h. Cells were stained
with anti-HA (green) to label N-terminally HA-
tagged NleH1 and Mitotracker (Invitrogen)
(red) and visualized by immunofluorescence
(a). The loss of viable mitochondria in TcdB-
treated cells is indicated by arrows in (b).
Expression of NleH1 prevented the rupturing
of mitochondria when cells were treated with
TcdB compared to mock-transfected cells or
transfected with the gfp control.
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in regulating critical anti-apoptotic pathways acting to curb
the apoptotic actions of TcdB on Rho GTPase signalling
and actin dynamics.
The third effect of TcdB is mitochondrial membrane
hyperpolarization (MMHP), which was shown to be
essential for TcdB-induced apoptosis (Matarrese et al.,
2007). TcdB was indicated to induce MMHP by blocking
mitochondrial ATP-dependent potassium (mKATP) chan-
nels, as activation of mKATP channels stopped TcdB-
induced apoptosis (Matarrese et al., 2007). An obvious
phenotype of blocking mKATP channels is the rupturing of
the mitochondrial membrane as a result of swelling
(Desagher & Martinou, 2000). The induction of MMHP
has been indicated as an early event in apoptosis (Gross
et al., 2000; Kroemer & Reed, 2000; Matarrese et al., 2007)
or results in the sensitization of cells to mitochondrial-
related apoptosis (Kroemer & Reed, 2000; Matarrese et al.,
2003, 2007). This was not the case in nleH1-transfected
cells, whose mitochondria were clearly not disrupted,
suggesting that mitochondrial membrane polarity must
still be intact; in addition they showed no signs of swelling.
Supporting this, downstream of mitochondrial pro-apop-
totic protein release, due to changes in mitochondrial
membrane polarity or swelling and rupture, is the cleavage
of caspase-3, which was not observed in nleH1-transfected
cells. Therefore NleH must act prior to mitochondrial
activation in the intrinsic apoptotic pathway, suggesting
that the upstream regulation of either pro- or anti-
apoptotic proteins is paramount.
It is also known that TcdB activation following endosomal
lysis and release into the cytosol causes an increase in HeLa
cell cytosolic Ca
2+ levels, thought to be derived not from
the ER Ca
2+ store but from the extracellular environment
(Matarrese et al., 2007). It has been reported that the
actions of TcdB are Ca
2+ dependent, as the lack of Ca
2+ in
TcdB-intoxicated cells does not induce apoptosis
(Matarrese et al., 2007).
Recently we showed that NleH inhibits Ca
2+ release from
the ER due to interaction with Bax inhibitor 1 (BI-1) a
known anti-apoptotic protein (Hemrajani et al., 2010).
Although Ca
2+ was shown to come from the extracellular
milieu for cells challenged solely with TcdB (Matarrese
et al., 2007), the regulation of Ca
2+ uptake and
cytoplasmic Ca
2+ concentration is influenced by NleH,
as infection with EPEC nleH mutants led to raised cytosolic
Ca
2+ levels (Hemrajani et al., 2010). The inhibition by
NleH of increasing a cell’s cytoplasmic Ca
2+ concentration
could explain why TcdB does not induce MMHP and
therefore apoptosis. However, the mechanism by which
BI-1 inhibits apoptosis is not fully known, although it is
known that it interacts with anti-apoptotic proteins Bcl-2
and Bcl-XL and blocks Bax-mediated apoptosis and that its
overexpression prevents chemically induced apoptosis by
staurosporine, tunicamycin, brefeldin A and thapsigargin
(Chae et al., 2004; Xu & Reed, 1998). The ability of BI-1 to
inhibit the induction of many forms of apoptosis could be
at the heart of how NleH1 prevents cell death from TcdB.
It is known that NleH effectors possess multiple domains,
one of which is a kinase domain (Gao et al., 2009;
Hemrajani et al., 2010). We have shown that the loss of this
domain does not affect the anti-apoptotic function of NleH
effectors either in the effector repertoire during EPEC
infection or during ectopic NleH expression when cells are
challenged with the pro-apoptotic compounds staurospor-
ine, tunicamycin and brefeldin A (Hemrajani et al., 2010).
In addition, Gao et al. (2009) showed the relevance of the
first 100 amino acids of NleH effectors in binding to the
ribosomal protein S3 (Rps3), a subunit of the nuclear
factor kappa-light-chain enhancer of activated B cells
(NFkB), regulating NFkB transcriptional activity. They
showed that NleH1 reduced the nuclear abundance of
Rps3, inhibiting NFkB activity.
NFkB plays a key role in regulating the immune response
to infection and anti-apoptotic genes. It was shown that the
loss of nleH1 from EHEC O157:H7 produced a hyper-
virulent form in gnotobiotic piglets, resulting in premature
death (Gao et al., 2009). This finding would suggest that
NleH1 itself is important for pathogenesis and that it has
relevance both to the clinical characteristic of EHEC and
EPEC infection and to proliferation in the host.
Furthermore, the anti-apoptotic effect of NleH1 is likely
to occur independently of the NFkB pathway, as its
inhibition could reduce the transcription of anti-apoptotic
host genes.
In this studywehaveconfirmed theability ofTcdBtotrigger
apoptosis. The induction of apoptosis by TcdB is likely to be
due to a number of different actions including inhibition of
Rho GTPases inducing cell rounding as well as mitochon-
drial hyperpermeability stimulating the intrinsic apoptotic
pathway. We have already shown that NleH can block
apoptosis induced by staurosporine, tunicamycin and
brefeldin A; its ability also to block TcdB-induced apoptosis
suggests that NleH targets a basic mechanism common to
these unrelated apoptosis pathways by acting on a global
anti-apoptotic pathway, independent of the NFkB pathway,
that is yet to be determined.
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